ArticleJournal of animal science2025
Effects of 3-nitrooxypropanol on methane emission, growth and feed intake in growing calves from 5 months of age.
Article in Journal of animal science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to test the effect of 3-nitrooxypropanol (3-NOP) on methane (CH4) emission, feed intake, and body weight (BW) of calves from 5 mo of age. Seventy calves were enrolled in the acclimatization period (3 wk), after which 60 calves were selected based on their ability to use the automated feed bins and the GreenFeed system. Calves (N = 60), a mixture of males and females and either Holstein Friesian or Belgian Blue, were blocked in pairs by sex, breed, and BW, and within block randomly assigned to 1 of 2 dietary treatments: a partially mixed ration (PMR) supplemented with (1) a placebo concentrate (CTL), or with (2) a 3-NOP concentrate (on average 121 mg 3-NOP/kg dry matter of total ration). The acclimatization period was followed by a baseline measurement period (2 wk), and afterwards the treatment period (12 wk) started where the calves received 1 of the 2 dietary treatments. The calves also received up to 1,280 g/day bait in the GreenFeed system, which was used for emission measurements. For analyses, all data were averaged for the baseline measurement period and for different periods in the treatment wk: 1-3, 4-6, 7-9 and 10-12. Upon 3-NOP supplementation, CH4 production (g/d) was reduced by 31.3% in wk 1-3, by 27.1% in wk 4-6, by 30.0% in wk 7-9, and by 30.7% in wk 10-12 compared to CTL (P < 0.01), and CH4 intensity (g/kg BW) was reduced by 30.0% in week 1-3, by 25.8% in wk 4-6, by 27.9% in wk 7-9, and by 28.6% in wk 10-12 compared to CTL (P < 0.01). Over the entire treatment period, 3-NOP calves had a reduction of 29.8% for CH4 production (P < 0.01), 19.4% for CH4 yield (g/kg dry matter intake; DMI) (P < 0.01), and 27.9% for CH4 intensity (g/kg BW) (P < 0.01). Calves receiving 3-NOP had a lower total DMI (6.1 kg/d) compared to CTL (6.9 kg/d) (P < 0.01), driven by a lower DMI of PMR. In every period, 3-NOP calves had a lower BW compared to CTL (over the entire treatment period: 251 vs. 258 kg, P < 0.01). The 3-NOP group and the CTL group did not differ in initial BW, but calves in the 3-NOP group had a lower final BW (290 kg) compared to CTL (301 kg) (P < 0.01). Despite the decreased DMI and growth performance, gain-to-feed ratio (kg BW gain/kg DMI) did not differ between the treatment groups. It can be concluded that 3-NOP persistently decreases CH4 emission in growing beef calves from 5 to 8 mo of age, but that it takes a longer period of time to grow the cattle to a similar body weight due to the decreased growth performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.